Ruth Kaplan

Health systems correspondent.

Ruth Kaplan covers hospitals, health systems and the business of care for Clinical Observer. She writes from published reporting, filings and official statements.

FDA advisory committees

FDA Adds Advisers as Review Finds Pharma Ties

A Health Affairs Scholar analysis found nearly 40 percent of FDA advisory meetings over two decades had patient or consumer reps tied to pharma-funded groups; most ties were not disclosed.

Illustration: FDA advisory committee meeting room